Pharma Companies Face 'Tremendous' Uncertainty in China, Corporate Panelists Say
Pfizer's Gary Giampetruzzi and Daiichi Sankyo's Richard Konzelmann discussed China's recent anti-corruption crackdown at a panel in Washington, D.C.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10